Patriot News Organization

If close friends and family members who contracted COVID-19 had mild cases and recovered quickly, or if they had an adverse reaction to the vaccine, your brain might convince you that you'd have the same experience. This phenomenon, known as…

HONG KONG (Reuters) -The latest wave of COVID-19 infections has “overwhelmed” Hong Kong, the city’s leader said on Monday as daily cases surged by some 20 times over the past two weeks, leaving hospitals short of beds and struggling to…

New research from the University of South Australia could deliver a breakthrough for children suffering one of the most severe forms of genetic epilepsy, reducing the frequency of their seizures and improving their quality of life. Malignant migrating partial seizures…

From the age of 25, cervical cancer screenings are advised – but one in three aren’t attending them. Despite calls for the starting age to be lowered along with changes in what specifically is tested for to make them even…

Measles: UNICEF warns Coronavirus could bring resurgence We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You…

Nanoknife: Expert discusses new prostate cancer treatment We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You…

The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant (B.1.1.529) is a major concern, even among vaccinated individuals. Study: Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients. Image Credit: Imilian/Shutterstock This…

(HealthDay)—The so-called “stealth” variant of Omicron isn’t likely to cause another devastating wave of COVID-19, experts say. The new version of the variant, called BA.2, doesn’t appear to cause more severe disease and vaccines are just as effective against it…

Emotional eating behavior may partly explain why some people don’t lose weight with a new type of treatment for obesity, glucagon-like peptide-1 (GLP-1) receptor agonists, new research suggests. Used to treat type 2 diabetes and obesity, GLP-1 agonists reduce blood…

Announcing a new review article publication for Acta Materia Medica journal. Quiescent cancer cells (QCCs) reversibly reside in G0 phase, thus allowing them to survive chemotherapy and radiotherapy, which generally target proliferating cells. Surviving QCCs may re-proliferate, and consequently result…